Kymab Access Ltd

Kymab Access is a unique program opening up access for academicians to fully human monoclonal antibodies generated by the Kymouse. Initially developed on funding from The Wellcome Trust, Kymouse is a brand new and state-of-the-art transgenic mouse for the generation of therapeutic MAbs.

Laura is working with Kymab Access to form alliances with top tier translational medicine researchers around the world. Groups whose research targets have demonstrated a strong scientific rationale for MAb intervention, with a clear path to the design of clinical studies and in a disease arena with unmet medical needs, are encouraged to contact Laura and to apply to the program.